Tolerance study of a triple first-line antiretroviral combination zidovudine, lamivudine and efavirenz in dakar, Senegal;Étude de la tolérance d'une trithérapie antirétrovirale de première intention associant zidovudine, lamivudine et efavirenz à dakar, Sénégal

Bulletin de la Societe de Pathologie Exotique

Volumn 102, Issue 2, 2009, Pages 99-100

  Seydi, M ^a   Diop, S A ^a   Dieng, A B ^a   Tekpa, G ^a   Soumare M ^a   Diouf, A ^a   Niang, Kh ^a   Lakh, A ^a   Ndiaye, I ^a   Fall, M B K ^a   Diop, B M ^a   Sow, Ab ^a   Sow, P S ^a  

^a Centre Hospitalier Universitaire Dakar   (Senegal)

Author keywords

Adverse effects; Antiretroviral; Dakar; Efavirenz; HIV; Hospital; Lamivudine; S n gal; Sub saharan africa; Zidovudine

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZOXAZINE DERIVATIVE; EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PHYSIOLOGY; SENEGAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANEMIA; ANTI-HIV AGENTS; BENZOXAZINES; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; HIV-1; HUMANS; LAMIVUDINE; SENEGAL; ZIDOVUDINE;

EID: 67649983046     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.3185/pathexo3328     Document Type: Article

References (6)

1. CHIFFOLEAU A, VEYRAC G, BRUNET-FRANCOIS C, RAFFI F, BOURIN M & JOLLIET P - Recueil systématique des effets indésirables des médicaments du VIH : bilan de 18 mois de collaboration du CISIH et du CRPV. La lettre dupharmacologue, 2002, 16, 123-129.
2. DANEL C, MOH R, ANZIAN A, ABO Y, CHENAL H et al. - Tolerance and Acceptability of an Efavirenz-Based Regimen in 740 Adults (Predominantly Women) in West Africa. J Acquir Immune Defic Syndr, 2006, 42, 29-35.
3. DESCLAUX A, CISS M, TAVERNE B, SOW PS, EGROT M et al. - Access to antiretroviral drugs and AIDS management in Senegal. AIDS, 2003, 17, 95-S101.
4. HOFFMANN CI, FIELDING KL, CHARALAMBOUS S, SULK- OWSKI MS, INNES C et al. - Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS, 2008, 22, 67-74.
5. ORG MOND SANTÉ - Antiretroviral therapy for HIV infection in adults and adolescents in resourcelimited settings: towards universal access recommendations for a public health approach. Genève, 2006, pp 7-10.
6. TASHIMA K, STASZEWSKI S, NELSON M, RACHLIS A, SKIEST D et al. - Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection. AIDS, 2008, 22, 275-279.